How Long Does Ketamine Last?

The answer depends on which effect you mean. During a supervised IV ketamine infusion, the dissociative and sedative effects generally build during the roughly 40- to 60-minute dosing window, taper as the infusion ends, and are largely gone within an hour or two afterward — most patients are steady enough to leave the clinic with a ride the same day. The antidepressant effect runs on a completely different clock: research on ketamine for treatment-resistant depression has repeatedly found that a single infusion's mood benefit can outlast the drug itself by days, with relief commonly reported in the several-days-to-about-a-week range — occasionally longer — even though ketamine has cleared from the bloodstream within hours. That gap between how long ketamine stays in your system and how long you actually feel better is the single most important thing to understand about its duration.

How Long the Acute Effects Last

Most ketamine treatment for depression, anxiety, or chronic pain is delivered as a slow IV drip rather than a single shot, and that pacing is deliberate. A typical session runs the actual dosing over roughly 40 to 60 minutes, a window clinics use because it lets the care team titrate the infusion rate against how a patient is responding in real time — slowing or pausing if dissociation, nausea, or a blood-pressure spike becomes uncomfortable. Effects usually build within the first 10 to 20 minutes: a floaty, detached feeling, altered perception of sound and time, sometimes mild visual distortion. Those sensations tend to peak somewhere near the end of the infusion and then taper as the drip winds down.

What happens next is the part most people actually want to know: recovery. After the infusion stops, the acute dissociative and sedative effects generally fade over the following hour or two, and most clinics keep patients in a recovery area — checking blood pressure, asking how they're feeling — until the care team is comfortable discharging them. That's typically same-day; you're not admitted overnight. But nearly every clinic requires a ride home and no driving for the rest of the day, since residual grogginess, slowed reaction time, or lingering dissociation can persist even after you feel mostly normal. The transient side effects that show up during and after dosing, along with the less common risks clinics screen for beforehand, are covered in ketamine's side effects and safety profile.

This "in the chair for about two hours total, acute effects gone within about an hour or two of the drip ending" pattern is specific to IV ketamine infusions, the most extensively studied delivery route for depression and the one most ketamine clinics build their protocols around. Other routes, covered further down, shift both the onset and the tail end of that timeline.

Ketamine's Half-Life

Half-life describes how long it takes the body to clear half of a drug from the bloodstream — a pharmacokinetic measurement, not a description of how a drug feels. For ketamine given intravenously, the commonly reported plasma elimination half-life falls in the range of roughly two to three hours. Practically, that means the large majority of the ketamine from a single infusion has been metabolized and cleared within about half a day, well after the acute psychoactive effects have already resolved.

Ketamine doesn't just disappear — the liver metabolizes it, primarily through cytochrome P450 enzymes, into norketamine, an active metabolite that still binds NMDA receptors, though less potently than the parent compound. Pharmacokinetic studies have found norketamine persists measurably longer than ketamine itself, with a longer elimination half-life than the parent drug. That's one reason researchers studying ketamine's antidepressant mechanism don't treat it as a single-molecule question — the drug you're given and the metabolite your body produces from it may both be contributing to what you feel, on two different clocks.

Clinicians sometimes distinguish between a drug's half-life and its duration of action — how long the clinical effect actually lasts — and ketamine is a clear example of why that distinction matters even within a single dose. A two-to-three-hour elimination half-life does not mean effects last two to three hours, and it doesn't mean they stop the moment the drug clears, either. The dissociative effects you notice during and shortly after an infusion track ketamine's concentration at NMDA receptors in the brain, which falls faster than overall blood levels once the infusion stops — that's the acute-effects timeline described above. The antidepressant effect follows an entirely separate, much longer timeline, discussed next, that has more to do with what the drug triggers in the brain than with how long any molecule of it remains in your system.

Why the Antidepressant Effect Outlasts the Drug

Perhaps the most studied and least intuitive fact about ketamine is that its mood effects persist long after the drug itself is gone. In controlled trials of IV ketamine for treatment-resistant depression, researchers have documented antidepressant responses beginning within hours of a single infusion and, in patients who respond, lasting for several days — commonly described in the literature as roughly a week, with some patients maintaining benefit longer and others relapsing sooner. That's the basis for describing ketamine's mood effect as lasting "several days to about a week" after one infusion — a documented range, not a guarantee, since individual response varies widely and not everyone responds meaningfully to a single dose. For a fuller picture of response rates and what the controlled-trial evidence actually shows, see how well ketamine works for depression.

The proposed explanation is mechanistic, not mysterious. Ketamine's NMDA-receptor blockade triggers a burst of glutamate signaling that, in preclinical and translational research, has been linked to rapid synaptogenesis — the growth of new connections between neurons, particularly in brain regions involved in mood regulation. That process is thought to unfold over hours to days, well past the point where ketamine itself has been eliminated from the bloodstream, which is the leading explanation for why the antidepressant window outlasts the drug's pharmacokinetic half-life by such a wide margin.

Because a single infusion's benefit is time-limited, virtually no ketamine clinic treats it as a one-and-done intervention for depression. Most build a protocol around an initial series of infusions delivered over two to three weeks, followed by less frequent maintenance sessions for patients who respond, specifically to keep re-triggering that window before the previous one fades. Exactly how many sessions that involves, and how protocols differ between an induction series and ongoing maintenance dosing, is covered in how many treatments you need.

How Route Changes Duration

IV infusion is the most heavily studied route, but it isn't the only one clinics use, and how ketamine is delivered changes both how quickly it takes effect and how long that effect takes to resolve.

Intramuscular (IM) injection reaches the bloodstream almost as efficiently as an IV line — pharmacokinetic research has found IM ketamine's bioavailability close to that of IV administration — but because it's a single shot rather than a titrated drip, onset is faster and less adjustable, and clinicians can't taper the dose mid-session the way they can with an infusion. Acute effects from an IM injection tend to come on faster and can feel more intense at the outset compared with a slowly titrated IV infusion, even when the total dose is similar.

Oral and sublingual (troche or lozenge) ketamine work on a slower, longer curve. Swallowed ketamine passes through the liver before it reaches general circulation — first-pass metabolism — which substantially reduces how much of the original drug reaches the bloodstream intact and converts a larger share of it to norketamine before it ever takes effect. Troches held under the tongue partly bypass that first pass by absorbing through the oral mucosa, but absorption is still slower and less predictable than an injected route. In practice, oral and sublingual ketamine typically have a slower onset and a longer, gentler effect curve than IV or IM dosing, which is part of why some at-home and maintenance programs use oral forms between in-clinic infusion series rather than as the primary induction treatment.

Intranasal esketamine (Spravato), the only ketamine-derived medicine with full FDA approval for treatment-resistant depression, follows a different protocol entirely. It's self-administered as a nasal spray under direct observation in a certified healthcare setting, and the FDA's Risk Evaluation and Mitigation Strategy (REMS) for the drug requires monitoring for at least two hours after each dose before a patient is allowed to leave, plus a requirement that patients not drive until the next day. That monitoring window exists because esketamine's acute dissociative and sedation effects follow a similar resolve-within-hours pattern to IV ketamine, even though the delivery route, dose, and exact pharmacokinetics differ. On duration specifically, both are built around the same principle: acute effects resolve within a monitored window measured in hours, while any antidepressant benefit is judged over days to weeks, not during the appointment itself.

Frequently Asked Questions

Every clinic structures its infusion length, monitoring window, and follow-up schedule slightly differently, so it's worth asking directly about session length and recovery-room time when you're evaluating providers. You can compare ketamine clinics in your state to see what treatments each one offers and how their protocols are described before booking a first appointment.

Sources: FDA prescribing information for ketamine (Ketalar) and esketamine (Spravato) nasal spray, the Spravato Risk Evaluation and Mitigation Strategy (REMS) program requirements, NIMH-funded controlled trials of IV ketamine for treatment-resistant depression, and peer-reviewed pharmacokinetic and pharmacology literature on ketamine and norketamine. Informational only — not medical advice. Talk with a licensed clinician about your health history before starting treatment.